High cholesterol, or hypercholesterolemia, affects nearly 1 in 3 American adults—yet it often goes undetected until a serious event like a heart attack or stroke occurs. It's one of the major ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

MADRID, Spain—The European Society of Cardiology and the European Atherosclerosis Society (ESC/EAS) have updated their guidelines for the management of dyslipidemia, and while treatment goals have ...

Experts say a few simple dietary changes could significantly reduce bad cholesterol and improve long-term cardiovascular ...

Every 40 seconds, someone in the U.S. has a heart attack or stroke, and in most cases, it’s their first. 1 The good news? The risk for these devastating events can actually be significantly reduced by ...

However, evidence of high cholesterol can appear in unexpected places, including the Achilles tendons, reports Surrey Live.

MOST of us know there’s ‘good’ and ‘bad’ cholesterol and this fatty substance in the blood can be ‘high’ or ‘low’. But there’s another ...

More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when ...

Very high levels are even more dangerous than better-known risks for heart-attack and stroke. “In individuals who don’t have heart disease, it seems it is equivalent to having two other modifiable ...

Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.

A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62 ...

For many women, the truest threat of menopause happens out of sight. Medical experts at the 18th Asian-Pacific Society of ...